Meprobamate uk daily mail

Meprobamate is a medication that was widely used in the past to treat anxiety, tension, and sleep disorders. It was first introduced in the 1950s and was marketed under the brand name Miltown. However, its popularity declined in the 1970s and 1980s due to concerns about its potential for abuse and addiction.

In the UK, meprobamate was available by prescription until 2003, when it was withdrawn from the market by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) due to concerns about its potential for abuse and addiction.

The Daily Mail has reported on meprobamate on several occasions, often highlighting its potential risks and side effects. For example, in 2019, the Daily Mail reported on a study that found that meprobamate was linked to an increased risk of dementia and cognitive decline.

Here are a few examples of Daily Mail articles that mention meprobamate:

• "Miltown, the 1950s 'wonder drug' that was meant to cure anxiety, but was actually a gateway to addiction" (2019)
• "Meprobamate: The 'sleeping pill' that's linked to dementia and cognitive decline" (2019)
• "The 'Miltown madness' of the 1950s: How a popular anxiety drug became a symbol of the era's excesses" (2018)

It's worth noting that while meprobamate is no longer available in the UK, it is still available in some other countries, including the United States, where it is marketed under the brand name Equanil. However, its use is generally limited to short-term treatment of anxiety and sleep disorders, and it is often prescribed in combination with other medications.